These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29253854)

  • 1. Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.
    Abdossamadi Z; Seyed N; Zahedifard F; Taheri T; Taslimi Y; Montakhab-Yeganeh H; Badirzadeh A; Vasei M; Gharibzadeh S; Rafati S
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006123. PubMed ID: 29253854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice.
    Abdossamadi Z; Taheri T; Seyed N; Montakhab-Yeganeh H; Zahedifard F; Taslimi Y; Habibzadeh S; Gholami E; Gharibzadeh S; Rafati S
    Immunotherapy; 2017 Oct; 9(13):1089-1102. PubMed ID: 29032739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
    Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
    Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Amphotericin B-Conjugated Functionalized Carbon Nanoparticles in the Treatment of Cutaneous Leishmaniasis.
    Heidari-Kharaji M; Guerra SS; Puneiad RP
    Parasite Immunol; 2024 Oct; 46(10):e13068. PubMed ID: 39363635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.
    Seif S; Kazemi F; Gholami E; Seyed N; Taslimi Y; Habibzadeh S; Azarian B; Jamshidi S; Hashemi M; Rafati S; Taheri T
    Appl Microbiol Biotechnol; 2016 May; 100(9):3923-34. PubMed ID: 26685673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
    Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis.
    Heidari-Kharaji M; Fallah-Omrani V; Badirzadeh A; Mohammadi-Ghalehbin B; Nilforoushzadeh MA; Masoori L; Montakhab-Yeganeh H; Zare M
    Parasite Immunol; 2019 Jan; 41(1):e12605. PubMed ID: 30472741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.
    Belkhelfa-Slimani R; Djerdjouri B
    Inflammopharmacology; 2018 Apr; 26(2):621-634. PubMed ID: 28988279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeopathic medicines cause Th1 predominance and induce spleen and megakaryocytes changes in BALB/c mice infected with Leishmania infantum.
    Cajueiro APB; Goma EP; Dos Santos HAM; Almeida Rodrigues I; Toma HK; Araújo SM; Bonamin LV; Gomes NBN; Castelo-Branco MTL; de Souza Dias EP; Dos Santos Pyrrho A; Holandino C
    Cytokine; 2017 Jul; 95():97-101. PubMed ID: 28254560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis.
    Valadares DG; Duarte MC; Ramírez L; Chávez-Fumagalli MA; Lage PS; Martins VT; Costa LE; Ribeiro TG; Régis WC; Soto M; Fernandes AP; Tavares CA; Coelho EA
    Parasitol Res; 2012 Oct; 111(4):1807-16. PubMed ID: 22797606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.
    Badirzadeh A; Taheri T; Taslimi Y; Abdossamadi Z; Heidari-Kharaji M; Gholami E; Sedaghat B; Niyyati M; Rafati S
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005774. PubMed ID: 28708893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB/c mice.
    Sghaier RM; Aissa I; Attia H; Bali A; Leon Martinez PA; Mkannez G; Guerfali FZ; Gargouri Y; Laouini D
    Parasitology; 2016 Oct; 143(12):1615-21. PubMed ID: 27312247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the long-term and short-term protection in mouse model of Leishmania major infection following vaccination with Live Iranian Lizard Leishmania mixed with chitin microparticles.
    Noroozbeygi M; Keshavarzian N; Haji Molla Hoseini M; Haghdoust S; Yeganeh F
    Parasite Immunol; 2024 Jan; 46(1):e13018. PubMed ID: 37987175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmanicidal potentials of
    Sharifi F; Sharififar F; Pournamdari M; Ansari M; Tavakoli Oliaee R; Bamorovat M; Khosravi A; Keyhani AR; Salarkia E; Mortazaeizdeh A; Dabiri S; Khamesipour A; Sharifi I
    J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34115583
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice.
    Miguel DC; Yokoyama-Yasunaka JK; Uliana SR
    PLoS Negl Trop Dis; 2008 Jun; 2(6):e249. PubMed ID: 18545685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
    Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
    Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
    Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
    Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with Leishmania major.
    Rafiee A; Riazi-Rad F; Darabi H; Khaze V; Javadian S; Ajdary S; Bahrami F; Alimohammadian MH
    Int J Pharm; 2014 May; 466(1-2):375-81. PubMed ID: 24657288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.